Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Lahey, Timothy ^a   Ghosh, Mimi ^a,f   Fahey, John V ^a   Shen, Zheng ^a   Mukura, Lucy R ^a   Song, Yan ^a   Cu Uvin, Susan ^b   Mayer, Kenneth H ^b   Wright, Peter F ^a   Kappes, John C ^c,d,e   Ochsenbauer, Christina ^c   Wira, Charles R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b BROWN UNIVERSITY   (United States)

^c University of Alabama at Birmingham   (United States)

^d University of Alabama at Birmingham   (United States)

^e University of Alabama at Birmingham   (United States)

^f GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; ELAFIN; GLYCOPROTEIN GP 160; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CHEMOKINE;

ADULT; ANTIBODY TITER; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; DISEASE TRANSMISSION; FEMALE; GENITAL SYSTEM; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNATE IMMUNITY; MAJOR CLINICAL STUDY; SEXUAL INTERCOURSE; VIRAL TROPISM; VIRUS LOAD; VIRUS STRAIN; COITUS; DEMOGRAPHY; DRUG EFFECT; FEMALE GENITAL SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE SYSTEM; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; RISK FACTOR; TROPISM; VAGINAL LAVAGE; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CHEMOKINES; COITUS; DEMOGRAPHY; DISEASE PROGRESSION; FEMALE; GENITALIA, FEMALE; HETEROSEXUALITY; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; MIDDLE AGED; RISK FACTORS; TROPISM; VAGINAL DOUCHING; VIRAL LOAD; YOUNG ADULT;

EID: 84861865825     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038100     Document Type: Article

References (47)

1. Weller S, Davis K, (2001) Condom effectiveness in reducing heterosexual HIV transmission. Cochrane database of systematic reviews.
2. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, et al. (2010) Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 375: 2092-2098.
3. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC,et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365: 493-505.
4. (WHO) WHO, (2007) AIDS Epidemic Update.
5. Hickey DK, Patel MV, Fahey JV, Wira CR, (2011) Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. Journal of reproductive immunology 88: 185-194.
6. Yeaman GR, White HD, Howell A, Prabhala R, Wira CR, (1998) The mucosal immune system in the human female reproductive tract: potential insights into the heterosexual transmission of HIV. AIDS research and human retroviruses 14 (Suppl 1): S57-62.
7. Hladik F, McElrath MJ, (2008) Setting the stage: host invasion by HIV. Nature Reviews Immunology 8: 447-457.
8. Wira CR, Patel MV, Ghosh M, Mukura L, Fahey JV, (2011) Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. American journal of reproductive immunology 65: 196-211.
9. Ghosh M, Fahey JV, Shen Z, Lahey T, Cu-Uvin S, et al. (2010) Anti-HIV activity in cervical-vaginal secretions from HIV-positive and-negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS ONE 5: e11366.
10. Pitchenik AE, Fischl MA, Dickinson GM, Becker DM, Fournier AM, et al. (1983) Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state. Annals of internal medicine 98: 277-284.
11. Fuchs D, Jager H, Popescu M, Reibnegger G, Werner ER, et al. (1990) Immune activation markers to predict AIDS and survival in HIV-1 seropositives. Immunology letters 26: 75-79.
12. Liu Z, Cumberland WG, Hultin LE, Prince HE, Detels R, et al. (1997) Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. Journal of acquired immune deficiency syndromes and human retrovirology: official publication of the International Retrovirology Association 16: 83-92.
13. Seth N, Kaufmann D, Lahey T, Rosenberg ES, Wucherpfennig KW, (2005) Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication. J Immunol 175: 6948-6958.
14. Klein MR, van Baalen CA, Holwerda AM, Kerkhof Garde SR, Bende RJ, et al. (1995) Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. The Journal of experimental medicine 181: 1365-1372.
15. Coombs RW, Collier AC, Allain JP, Nikora B, Leuther M, et al. (1989) Plasma viremia in human immunodeficiency virus infection. The New England journal of medicine 321: 1626-1631.
16. Cu-Uvin S, Caliendo AM, (1997) Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women. Obstetrics and gynecology 90: 739-743.
17. Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, et al. (1991) Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and-defective viral genomes. J Virol 65: 3973-3985.
18. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, et al. (2008) Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105: 7552-7557.
19. Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, et al. (2009) Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 206: 1273-1289.
20. Ochsenbauer C, Edmonds TG, Ding H, Keele BF, Decker J, et al. (2011) Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of their Replication Capacity in CD4 T-Lymphocytes and Monocyte-derived Macrophages. J Virol Epub Date 2011/12/ 23.
21. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, et al. (2002) Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 46: 1896-1905.
22. Montefiori DC, (2010) Protocol for Neutralizing Antibody Screening Assay for HIV-1 in TZM-bl Cellshttp://wwwhivlanlgov/content/nab-reference-strains/html/Protocol-for-Neutralizing-Antibody-Screening-Assay-for-HIV-1-in-TZM-bl-Cells-November-2010pdf.
23. Montefiori DC, (2009) Measuring HIV neutralization in a luciferase reporter gene assay. Methods in molecular biology 485: 395-405.
24. Fahey JV, Schaefer TM, Channon JY, Wira CR, (2005) Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract. Hum Reprod 20: 1439-1446.
25. Wright PF, Kozlowski PA, Rybczyk GK, Goepfert P, Staats HF, et al. (2002) Detection of mucosal antibodies in HIV type 1-infected individuals. AIDS research and human retroviruses 18: 1291-1300.
26. Oswald-Richter K, Grill SM, Shariat N, Leelawong M, Sundrud MS, et al. (2004) HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS biology 2: E198.
27. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, et al. (2000) Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. The New England journal of medicine 342: 921-929.
28. Tuomala RE, O'Driscoll PT, Bremer JW, Jennings C, Xu C, et al. (2003) Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. The Journal of infectious diseases 187: 375-384.
29. Baeten JM, Kahle E, Lingappa JR, Coombs RW, Delany-Moretlwe S, et al. (2011) Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Science translational medicine 3: 77ra29.
30. Ghosh M, Shen Z, Fahey JV, Cu-Uvin S, Mayer K, et al. (2010) Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract. Immunology 129: 207-219.
31. Keller MJ, Guzman E, Hazrati E, Kasowitz A, Cheshenko N, et al. (2007) PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity. AIDS 21: 467-476.
32. Venkataraman N, Cole AL, Svoboda P, Pohl J, Cole AM, (2005) Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid. Journal of immunology 175: 7560-7567.
33. Blaak H, van't Wout AB, Brouwer M, Cornelissen M, Kootstra NA, et al. (1998) Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmission in homosexual couples. Journal of virology 72: 218-224.
34. Pitt J, Schluchter M, Jenson H, Kovacs A, LaRussa P, et al. (1998) Maternal and perinatal factors related to maternal-infant transmission of HIV-1 in the P2C2 HIV study: the role of EBV shedding. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV-1 Infection (P2C2 HIV) Study Group. Journal of acquired immune deficiency syndromes and human retrovirology: official publication of the International Retrovirology Association 19: 462-470.
35. Ishikawa C, Tanabe H, Maemoto A, Ito T, Watari J, et al. (2009) Precursor processing of human defensin-5 is essential to the multiple functions in vitro and in vivo. Journal of innate immunity 2: 66-76.
36. Guyot N, Zani ML, Berger P, Dallet-Choisy S, Moreau T, (2005) Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin. Biological chemistry 386: 391-399.
37. Hasan L, Mazzucchelli L, Liebi M, Lis M, Hunger RE, et al. (2006) Function of liver activation-regulated chemokine/CC chemokine ligand 20 is differently affected by cathepsin B and cathepsin D processing. Journal of immunology 176: 6512-6522.
38. Taggart CC, Greene CM, Smith SG, Levine RL, McCray PB Jr, et al. (2003) Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins. Journal of immunology 171: 931-937.
39. Yamasaki K, Schauber J, Coda A, Lin H, Dorschner RA, et al. (2006) Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 20: 2068-2080.
40. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, et al. (1997) HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350: 546-550.
41. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS, (2008) Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 22: 1493-1501.
42. Wira CR, Fahey JV, (2008) A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. Aids 22: 1909-1917.
43. King AE, Morgan K, Sallenave JM, Kelly RW, (2003) Differential regulation of secretory leukocyte protease inhibitor and elafin by progesterone. Biochemical and biophysical research communications 310: 594-599.
44. King AE, Critchley HO, Sallenave JM, Kelly RW, (2003) Elafin in human endometrium: an antiprotease and antimicrobial molecule expressed during menstruation. The Journal of clinical endocrinology and metabolism 88: 4426-4431.
45. King AE, Critchley HO, Kelly RW, (2003) Innate immune defences in the human endometrium. Reproductive biology and endocrinology 1: 116.
46. Fahey JV, Wira CR, (2002) Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. The Journal of infectious diseases 185: 1606-1613.
47. Fahey JV, Wright JA, Shen L, Smith JM, Ghosh M, et al. (2008) Estradiol selectively regulates innate immune function by polarized human uterine epithelial cells in culture. Mucosal immunology 1: 317-325.